Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Absci Corp (ABSI)

Absci Corp (ABSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Absci Corp 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683 USA

www.absci.com P: 360-949-1041

Description:

Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The company's Creation(TM) Platform involved in discovery of novel biotherapeutic drug candidates and generation of the cell lines to manufacture them in a single efficient process. Absci Corporation is based in VANCOUVER, Wash.

Key Statistics

Overview:

Market Capitalization, $K 503,785
Enterprise Value, $K 423,145
Shares Outstanding, K 113,083
Annual Sales, $ 5,720 K
Annual Net Income, $ -110,570 K
Last Quarter Sales, $ 340 K
Last Quarter Net Income, $ -23,550 K
EBIT, $ -80,190 K
EBITDA, $ -44,860 K
60-Month Beta 2.36
% of Insider Shareholders 11.58%
% of Institutional Shareholders 52.05%
Float, K 99,988
% Float 88.42%
Short Volume Ratio 0.28

Growth:

1-Year Return 213.79%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 03/21/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm -1.02
EPS Growth vs. Prev Qtr -4.17%
EPS Growth vs. Prev Year -19.05%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ABSI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -44.52%
Return-on-Assets % -37.35%
Profit Margin % -1,933.04%
Debt/Equity 0.04
Price/Sales 89.59
Price/Cash Flow N/A
Price/Book 2.48
Book Value/Share 1.90
Interest Coverage -108.38
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar